Identity
HGNC
LOCATION
4p15.2
LOCUSID
ALIAS
NAPI-3B,NAPI-IIb,NPTIIb,PULAM
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 10568
MIM: 604217
HGNC: 11020
Ensembl: ENSG00000157765
Variants:
dbSNP: 10568
ClinVar: 10568
TCGA: ENSG00000157765
COSMIC: SLC34A2
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38720472 | 2024 | SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma. | 1 |
| 38720472 | 2024 | SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma. | 1 |
| 37259144 | 2023 | New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review. | 0 |
| 37259144 | 2023 | New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review. | 0 |
| 35443721 | 2022 | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis. | 3 |
| 35443721 | 2022 | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis. | 3 |
| 34944522 | 2021 | Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases. | 4 |
| 34944522 | 2021 | Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases. | 4 |
| 31540980 | 2020 | Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. | 14 |
| 31831582 | 2020 | Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis. | 11 |
| 32005974 | 2020 | SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. | 21 |
| 31540980 | 2020 | Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. | 14 |
| 31831582 | 2020 | Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis. | 11 |
| 32005974 | 2020 | SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. | 21 |
| 30038060 | 2019 | The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer. | 14 |
Citation
Dessen P
SLC34A2 (solute carrier family 34 member 2)
Atlas Genet Cytogenet Oncol Haematol. 2010-12-01
Online version: http://atlasgeneticsoncology.org/gene/51842/slc34a2
